CN|EN

news

  • Huahai attends the 19th CPhI & P-MEC China 2019

    June 18-20th,Huahai attended the 19th CPhI & P-MEC China 2019 which was heldin Shanghai new international expo center. The annual CPhi& P-MEC China exhibition is one of theworld's leading professional trade and exchange events of the vertical industrial chain...
  • Huahai volunteers carry out public welfare activi...

    On June 4th,more than 30 volunteers of Huahai Pharmaceutical went to Zhenhua School.They sent books, basketball, football, badminton and other recreational and sports articles to the children as present and draw environmental T-shirt with children. As a "social ...
  • The first anti-infection products of Huahai was of...

    The 2019 China hematology conference was held at the Wuhan international conference center on May 24--26.At the meeting, Eclican ® (voriconazole tablet), the first anti-infection products of Huahai was officially listed in China. Eclick ® (voriconazoletable...
  • Huahai ranks No.1 of top 10 export enterprises in ...

    Recently, China chamber of commerce ofmedicines & health products imports & exports released the list of top10 export enterprises in China's generic medicines industry in 2018, Huahaipharmaceutical co., ltd. ranked first again after topping the list in 2017, andalso won the...
  • Huahai US Inc. attends the DCAT Week in New York C...

    Representatives from Huahai US Inc. attended the DCAT Week in New York City during March 18th -21st. Huahai US Inc. hosted a wine tasting party and invited nearly 100 business partners to share business ideas during the week. Huahai US Inc. is a subsidiary company of Zhe...
Copyright 2018 Zhejiang Huahai Pharmaceutical Co., Ltd Zhejiang ICP is No. 05005324. Designed by Wanhu.